Sienna Biopharmaceuticals, Inc. (SNNAQ)
Develops topical drugs to treat skin conditions like psoriasis and eczema.
$0.00+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+0.0%
The outlook
SNNAQ is trading at $0.0001, sitting above both its 50- and 200-day moving averages. Analyst coverage appears minimal or unavailable for this microcap stock. The current price positioning suggests it's in an uptrend relative to intermediate-term benchmarks, though trading activity at this price level is extremely limited.
What’s behind the score
Price trendAbove its 50- & 200-day averages
Market cap
$3,090
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—